Cargando…

Serum albumin-mediated strategy for the effective targeting of SARS-CoV-2

Novel coronavirus (NCoV-19), also known as SARS CoV-2, is a pathogen causing an emerging infection that rapidly increases in incidence and geographic range, is associated with the ever-increasing morbidity and mortality rates, and shows sever economic impact worldwide. The WHO declares the NCoV-19 i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mani Mishra, Pushpendra, Uversky, Vladimir N., Nandi, Chayan K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195355/ https://www.ncbi.nlm.nih.gov/pubmed/32353740 http://dx.doi.org/10.1016/j.mehy.2020.109790

Ejemplares similares

SARS-CoV-2 Spike mutations modify the interaction between virus Spike and human ACE2 receptors
por: Mishra, Pushpendra Mani, et al.
Publicado: (2022)

Intrinsically disordered proteins of viruses: Involvement in the mechanism of cell regulation and pathogenesis
por: Mishra, Pushpendra Mani, et al.
Publicado: (2020)

Magnetofluorescent Nanoprobe for Multimodal and Multicolor Bioimaging
por: Yadav, Aditya, et al.
Publicado: (2020)

SARS-CoV-2 Bound Human Serum Albumin and Systemic Septic Shock
por: Johnson, Andrew S., et al.
Publicado: (2020)

SARS-CoV-2: A Master of Immune Evasion
por: Rubio-Casillas, Alberto, et al.
Publicado: (2022)

Insights into the structural properties of SARS-CoV-2 main protease
por: Akbayrak, Ibrahim Yagiz, et al.
Publicado: (2022)

Intrinsic disorder perspective of an interplay between the renin-angiotensin-aldosterone system and SARS-CoV-2
por: Elrashdy, Fatma, et al.
Publicado: (2020)

A Possible Path towards Rapid Development of Live-Attenuated SARS-CoV-2 Vaccines: Plunging into the Natural Pool
por: Todorov, German, et al.
Publicado: (2020)

Does SARS-CoV-2 Induce IgG4 Synthesis to Evade the Immune System?
por: Rubio-Casillas, Alberto, et al.
Publicado: (2023)

In silico identification of promising inhibitor against RNA-dependent RNA polymerase target of SARS-CoV-2
por: Singh, Pushpendra, et al.
Publicado: (2021)

Structural evolution of Delta lineage of SARS-CoV-2
por: Gomari, Mohammad Mahmoudi, et al.
Publicado: (2023)

Strategies for Targeting SARS CoV-2: Small Molecule Inhibitors—The Current Status
por: Beeraka, Narasimha M., et al.
Publicado: (2020)

Targets and strategies for vaccine development against SARS-CoV-2
por: Malik, Jonaid Ahmad, et al.
Publicado: (2021)

Protein Intrinsic Disorder and Evolvability of MERS-CoV
por: Uversky, Vladimir N., et al.
Publicado: (2021)

Plant Alkaloids Inhibit Membrane Fusion Mediated by Calcium and Fragments of MERS-CoV and SARS-CoV/SARS-CoV-2 Fusion Peptides
por: Shekunov, Egor V., et al.
Publicado: (2021)

Hotspot Mutations in SARS-CoV-2
por: Saha, Indrajit, et al.
Publicado: (2021)

Natural resources to control COVID-19: could lactoferrin amend SARS-CoV-2 infectivity?
por: Mattar, Ehab H., et al.
Publicado: (2021)

SARS-CoV-2 spike protein inhibits megalin-mediated albumin endocytosis in proximal tubule epithelial cells
por: Silva-Aguiar, Rodrigo P., et al.
Publicado: (2022)

Innate Immunity Evasion Strategies of Highly Pathogenic Coronaviruses: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Li, Jin-Yan, et al.
Publicado: (2021)

SARS-CoV-2-mediated evasion strategies for antiviral interferon pathways
por: Oh, Soo-Jin, et al.
Publicado: (2022)

Structural and functional significance of the amino acid differences Val(35)Thr, Ser(46)Ala, Asn(65)Ser, and Ala(94)Ser in 3C-like proteinases from SARS-CoV-2 and SARS-CoV
por: Denesyuk, Alexander I., et al.
Publicado: (2021)

Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection
por: Lin, Qingqing, et al.
Publicado: (2020)

A Study on the Nature of SARS-CoV-2 Using the Shell Disorder Models: Reproducibility, Evolution, Spread, and Attenuation
por: Goh, Gerard Kian-Meng, et al.
Publicado: (2022)

Identification of SARS-CoV-2 surface therapeutic targets and drugs using molecular modeling methods for inhibition of the virus entry
por: Farhadian, Sadegh, et al.
Publicado: (2022)

Understanding COVID-19 via comparative analysis of dark proteomes of SARS-CoV-2, human SARS and bat SARS-like coronaviruses
por: Giri, Rajanish, et al.
Publicado: (2020)

The immune response and immune evasion characteristics in SARS-CoV, MERS-CoV, and SARS-CoV-2: Vaccine design strategies
por: Molaei, Soheila, et al.
Publicado: (2021)

Trends in MERS-CoV, SARS-CoV, and SARS-CoV-2 (COVID-19) Diagnosis Strategies: A Patent Review
por: Nascimento Junior, José Adão Carvalho, et al.
Publicado: (2020)

IgG4 Antibodies Induced by Repeated Vaccination May Generate Immune Tolerance to the SARS-CoV-2 Spike Protein
por: Uversky, Vladimir N., et al.
Publicado: (2023)

The Importance of Research on the Origin of SARS-CoV-2
por: Lundstrom, Kenneth, et al.
Publicado: (2020)

An integrated understanding of the evolutionary and structural features of the SARS-CoV-2 spike receptor binding domain (RBD)
por: Sanyal, Dwipanjan, et al.
Publicado: (2022)

PEGylated nanoparticle albumin-bound steroidal ginsenoside derivatives ameliorate SARS-CoV-2-mediated hyper-inflammatory responses
por: Park, Hee Ho, et al.
Publicado: (2021)

Shell disorder analysis predicts greater resilience of the SARS-CoV-2 (COVID-19) outside the body and in body fluids
por: Goh, Gerard Kian-Meng, et al.
Publicado: (2020)

Comparison and Analysis of Neutralizing Antibody Levels in Serum after Inoculating with SARS-CoV-2, MERS-CoV, or SARS-CoV Vaccines in Humans
por: Yu, Sicong, et al.
Publicado: (2021)

Drug Discovery Strategies for SARS-CoV-2
por: Shyr, Zeenat A., et al.
Publicado: (2020)

Surgical Strategies in the Era of SARS-CoV-2
por: Dimitroulis, Dimitrios, et al.
Publicado: (2020)

SARS-CoV-2 S Glycoprotein Stabilization Strategies
por: Pedenko, Borys, et al.
Publicado: (2023)

Targeted photodynamic neutralization of SARS-CoV-2 mediated by singlet oxygen
por: Yao, Ruhui, et al.
Publicado: (2023)

Insights into the structural peculiarities of the N-terminal and receptor binding domains of the spike protein from the SARS-CoV-2 Omicron variant
por: Bayani, Fatemeh, et al.
Publicado: (2022)

Molecular structure analyses suggest strategies to therapeutically target SARS-CoV-2
por: Zhang, Yi, et al.
Publicado: (2020)

Mitochondria Targeted Viral Replication and Survival Strategies—Prospective on SARS-CoV-2
por: Gatti, Priya, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ok0a0f8o3ero5o4ju665ili44k